Mogy Joel R Investment Counsel Inc. boosted its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 97.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 86,430 shares of the company’s stock after buying an additional 42,640 shares during the quarter. Mogy Joel R Investment Counsel Inc. owned approximately 0.06% of Henry Schein worth $7,086,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. Bronfman E.L. Rothschild L.P. lifted its stake in Henry Schein by 89.3% in the 3rd quarter. Bronfman E.L. Rothschild L.P. now owns 28,130 shares of the company’s stock valued at $2,306,000 after buying an additional 13,271 shares in the last quarter. Norinchukin Bank The lifted its stake in Henry Schein by 114.5% in the 3rd quarter. Norinchukin Bank The now owns 11,809 shares of the company’s stock worth $968,000 after purchasing an additional 6,303 shares in the last quarter. ING Groep NV purchased a new position in Henry Schein in the 3rd quarter worth approximately $429,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Henry Schein by 145.4% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 32,720 shares of the company’s stock worth $2,683,000 after purchasing an additional 19,385 shares in the last quarter. Finally, Meiji Yasuda Asset Management Co Ltd. lifted its stake in Henry Schein by 95.2% in the 3rd quarter. Meiji Yasuda Asset Management Co Ltd. now owns 12,212 shares of the company’s stock worth $1,001,000 after purchasing an additional 5,956 shares in the last quarter. 63.60% of the stock is currently owned by hedge funds and other institutional investors.

A number of research analysts have weighed in on the stock. Royal Bank Of Canada decreased their target price on shares of Henry Schein from $91.00 to $82.00 and set a “sector perform” rating on the stock in a research note on Tuesday, November 7th. Jefferies Group LLC reissued a “hold” rating and issued a $89.00 target price on shares of Henry Schein in a research note on Friday, October 20th. Credit Suisse Group reissued a “hold” rating and issued a $87.50 target price on shares of Henry Schein in a research note on Tuesday, August 29th. Leerink Swann reissued a “market perform” rating and issued a $77.00 target price (down from $87.50) on shares of Henry Schein in a research note on Tuesday, November 7th. Finally, Morgan Stanley assumed coverage on shares of Henry Schein in a research note on Thursday, September 21st. They issued an “equal weight” rating and a $88.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and seven have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $89.88.

In other news, SVP Paul Rose sold 2,126 shares of the firm’s stock in a transaction that occurred on Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. Following the completion of the sale, the senior vice president now owns 17,841 shares in the company, valued at approximately $3,077,750.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 1.19% of the stock is owned by company insiders.

Shares of Henry Schein, Inc. (NASDAQ:HSIC) traded up $1.98 during midday trading on Thursday, hitting $69.95. 2,831,600 shares of the stock were exchanged, compared to its average volume of 1,184,590. The firm has a market cap of $10,668.19, a P/E ratio of 19.07, a P/E/G ratio of 1.91 and a beta of 1.03. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.55 and a quick ratio of 0.86. Henry Schein, Inc. has a fifty-two week low of $65.28 and a fifty-two week high of $93.50.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Monday, November 6th. The company reported $0.87 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.90 by ($0.03). The firm had revenue of $3.16 billion for the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The firm’s quarterly revenue was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.84 EPS. equities research analysts forecast that Henry Schein, Inc. will post 3.6 earnings per share for the current fiscal year.

Henry Schein announced that its board has authorized a stock buyback plan on Monday, September 18th that authorizes the company to repurchase $400.00 million in shares. This repurchase authorization authorizes the company to buy up to 6.3% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board believes its shares are undervalued.

WARNING: This article was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/11/23/mogy-joel-r-investment-counsel-inc-raises-position-in-henry-schein-inc-hsic.html.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.